Cargando…

Cystic Fibrosis: Breakthrough Drugs at Break-the-Bank Prices

Detalles Bibliográficos
Autores principales:	Orenstein, David M., O'Sullivan, Brian P., Quinton, Paul M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Global Advances in Health and Medicine 2015
Materias:	Viewpoints
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653607/ https://www.ncbi.nlm.nih.gov/pubmed/26659555 http://dx.doi.org/10.7453/gahmj.2015.123

Ejemplares similares

International reference pricing for prescription drugs: a landscape analysis
por: Rand, Leah Z, et al.
Publicado: (2021)

International reference pricing of pharmaceuticals in the United States: Implications for potentially curative treatments
por: Sullivan, Sean D, et al.
Publicado: (2022)

Thyroid glands from pigs with cystic fibrosis, old issues new ways
por: Scholte, Bob J
Publicado: (2010)

Patient and Family Participation in Clinical Guidelines Development: The Cystic Fibrosis Foundation Experience
por: Hempstead, Sarah E, et al.
Publicado: (2020)

The Pricing of Breakthrough Drugs: Theory and Policy Implications
por: Levy, Moshe, et al.
Publicado: (2014)

Orthopedic Tourism and Volunteerism: Joint Effort or Disjointed Mobility?
por: O’Sullivan, David, et al.
Publicado: (2021)

Breaking Convention for Another Dimension
por: Patel, Jignesh A.
Publicado: (2019)

Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs
por: Dzinamarira, Tafadzwa, et al.
Publicado: (2022)

The World Health Organization/World Bank’s first World Report on Disability
por: Seelman, Katherine D.
Publicado: (2011)

Pharmacy’s Call for Authorities to Aggressively Enforce Laws Addressing Price Gouging
por: Mattingly, T. Joseph, et al.
Publicado: (2020)

LGBTQ+ in Cardiology: Breaking Down the Closet Door
por: Cook, Stephen C.
Publicado: (2022)

Collective pharmaceutical procurement in China may have unintended consequences in supply and pricing
por: Jiang, Shan, et al.
Publicado: (2020)

Cystic and alveolar echinococcosis: Successes and continuing challenges
por: Budke, Christine M., et al.
Publicado: (2017)

Breaking Banks
por: King, Brett
Publicado: (2014)

Empyema in a Woman with Cystic Fibrosis: A Cautionary Tale
por: Coates, Anne, et al.
Publicado: (2013)

Breaking the cycle of the COVID-19 transmission: A challenge for Nigeria
por: Garba, Bashiru, et al.
Publicado: (2020)

Cystic Echinococcosis: Chronic, Complex, and Still Neglected
por: Brunetti, Enrico, et al.
Publicado: (2011)

A Call to Action Against Persistent Lack of Transparency in Vaccine Pricing Practices During the COVID-19 Pandemic
por: Arguedas-Ramírez, Gabriela
Publicado: (2022)

Cystic echinococcosis in the Eastern Mediterranean region: Neglected and prevailing!
por: Borhani, Mehdi, et al.
Publicado: (2020)

Enhancing Data Linkage to Break the Chain of COVID-19 Spread: The Taiwan Experience
por: Lo, Wei-Cheng, et al.
Publicado: (2021)

Optimal Detection of Cardiac Sequelae: The Need for Rigorous, Harmonized Magnetic Resonance Studies in Pediatric Survivors
por: Toro, Claudia, et al.
Publicado: (2021)

Breaking Specialty Silos: Improving Global Child Health Through Essential Surgical Care
por: Wasserman, Isaac, et al.
Publicado: (2020)

Breaking the World Bank.
por: Tibbetts, J
Publicado: (1995)

Low Beta-Adrenergic Sweat Responses in Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome Children
por: Salinas, Danieli Barino, et al.
Publicado: (2017)

Breaking through a phylogenetic impasse: a pair of associated archaea might have played host in the endosymbiotic origin of eukaryotes
por: Godde, James S
Publicado: (2012)

Tracing the source of infection of cystic and alveolar echinococcosis, neglected parasitic infections with long latency: The shaky road of “evidence” gathering
por: Casulli, Adriano, et al.
Publicado: (2021)

The altered gut microbiota in adults with cystic fibrosis
por: Burke, D.G., et al.
Publicado: (2017)

Can a bank crisis break your heart?
por: Stuckler, David, et al.
Publicado: (2008)

Assessment of the microbial load of airway clearance devices used by a cohort of children with cystic fibrosis
por: Linnane, B., et al.
Publicado: (2021)

Coronavirus disease 2019-associated pulmonary fibrosis: clinical findings, pathogenesis, and potential treatment
por: Jiang, Ya-Le, et al.
Publicado: (2021)

Erratum to: The altered gut microbiota in adults with cystic fibrosis
por: Burke, D.G., et al.
Publicado: (2017)

Breaking the Bank? A Probabilistic Assessment of Euro Area Bank Profitability()
por: Elekdag, Selim, et al.
Publicado: (2020)

The Lung Microbiome in Young Children with Cystic Fibrosis: A Prospective Cohort Study
por: Linnane, Barry, et al.
Publicado: (2021)

Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
por: Glebov, Oleg O.
Publicado: (2020)

Evaluation of Aerosol Therapy during the Escalation of Care in a Model of Adult Cystic Fibrosis
por: Fernández Fernández, Elena, et al.
Publicado: (2021)

Drugging the microbiome
por: Nagler, Cathryn R.
Publicado: (2020)

Best Practices for Integrating Medical Students Into Telehealth Visits
por: Wamsley, Maria, et al.
Publicado: (2021)

Accelerating drug discovery for pregnant and lactating women living with HIV
por: Hoffman, Risa M, et al.
Publicado: (2021)

Eliminating Mother-to-Child Transmission of HIV by 2030: 5 Strategies to Ensure Continued Progress
por: Vrazo, Alexandra C., et al.
Publicado: (2018)

Illicit drug use in Australia during the COVID-19 pandemic
por: Loi, Natasha M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j1itkl0rsglmuh4eb05qidd79r